Beam Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| BEAM-101 | Sickle Cell Disease / Beta-Thalassemia | Phase 1/2 |
| BEAM-102 | Sickle Cell Disease | Preclinical |
| BEAM-201 | Acute Myeloid Leukemia / R/R T-ALL | Phase 1/2 |
| BEAM-301 | Glycogen Storage Disease Type Ia (GSDIa) | Preclinical |
| BEAM-302 | Alpha-1 Antitrypsin Deficiency (AATD) | Phase 1/2 |